Risk of infectious complications after transperineal prostate biopsy compared to transrectal biopsy : nationwide population-based cohort study in Sweden
(2026) In Scandinavian Journal of Urology 61. p.44-50- Abstract
OBJECTIVE: Prostate biopsy is associated with a risk of significant infectious complications including sepsis. We investigated the risk of infections after transrectal (TR) biopsy compared to transperineal (TP) biopsy. MATERIALS AND METHODS: Men who had undergone prostate biopsy and diagnosed with prostate cancer were identified in the National Prostate Cancer Register (NPCR) of Sweden. Linkage with Swedish health care registers provided information on hospitalization, antibiotic prescriptions and comorbidities. Rate ratios for hospitalization, for infections, after TR and TP biopsies over day 1-7, 1-14, and 1-30 were estimated with Poisson regression. Filled prescriptions for urinary tract related antibiotics were also assessed.... (More)
OBJECTIVE: Prostate biopsy is associated with a risk of significant infectious complications including sepsis. We investigated the risk of infections after transrectal (TR) biopsy compared to transperineal (TP) biopsy. MATERIALS AND METHODS: Men who had undergone prostate biopsy and diagnosed with prostate cancer were identified in the National Prostate Cancer Register (NPCR) of Sweden. Linkage with Swedish health care registers provided information on hospitalization, antibiotic prescriptions and comorbidities. Rate ratios for hospitalization, for infections, after TR and TP biopsies over day 1-7, 1-14, and 1-30 were estimated with Poisson regression. Filled prescriptions for urinary tract related antibiotics were also assessed. RESULTS: Thirty-one thousand two hundred twenty-two men underwent biopsy between 1 January 2020 and 31 December 2023. 87% underwent TR and 13% TP biopsy. Hospitalization occurred in 0.6% of men (n = 24) after TP biopsy and 2.0% (n = 548) after TR biopsy. Rate ratios for hospitalization in the TR group compared to TP were 8.0 (95% confidence interval [CI]: 4.0-16.2) for day 1-7, 6.2 (3.2-11.9) for day 1-14, and 4.1 (2.4-6.8) for day 1-30. Filled antibiotic prescriptions were found for 4.5% of men (n = 187) after TP biopsy and 6.9% (n = 1,883) after TR biopsy. For antibiotic prescriptions, the rate ratios were 2.3 (1.8-2.9) for day 1-7 as well as day 1-14, and 1.6 (1.3-1.9) for day 1-30. CONCLUSIONS: A transrectal prostate biopsy was associated with a significantly higher risk of post-biopsy infectious complications compared to transperineal biopsy. These findings support the use of transperineal biopsy.
(Less)
- author
- organization
-
- Clinical Sciences, Helsingborg
- Translational Sepsis research (research group)
- Lund University Press
- Department of Clinical Sciences, Lund
- Infect@LU
- Heparin bindning protein in cardiothoracic surgery (research group)
- SEBRA Sepsis and Bacterial Resistance Alliance (research group)
- Infection Medicine (BMC)
- publishing date
- 2026-03-17
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Scandinavian Journal of Urology
- volume
- 61
- pages
- 7 pages
- publisher
- Taylor & Francis
- external identifiers
-
- scopus:105034121104
- pmid:41841614
- ISSN
- 2168-1813
- DOI
- 10.2340/sju.v61.45537
- language
- English
- LU publication?
- yes
- id
- c8f8f192-e38b-47f1-9163-e37c71498f36
- date added to LUP
- 2026-05-20 16:49:17
- date last changed
- 2026-05-20 16:50:18
@article{c8f8f192-e38b-47f1-9163-e37c71498f36,
abstract = {{<p>OBJECTIVE: Prostate biopsy is associated with a risk of significant infectious complications including sepsis. We investigated the risk of infections after transrectal (TR) biopsy compared to transperineal (TP) biopsy. MATERIALS AND METHODS: Men who had undergone prostate biopsy and diagnosed with prostate cancer were identified in the National Prostate Cancer Register (NPCR) of Sweden. Linkage with Swedish health care registers provided information on hospitalization, antibiotic prescriptions and comorbidities. Rate ratios for hospitalization, for infections, after TR and TP biopsies over day 1-7, 1-14, and 1-30 were estimated with Poisson regression. Filled prescriptions for urinary tract related antibiotics were also assessed. RESULTS: Thirty-one thousand two hundred twenty-two men underwent biopsy between 1 January 2020 and 31 December 2023. 87% underwent TR and 13% TP biopsy. Hospitalization occurred in 0.6% of men (n = 24) after TP biopsy and 2.0% (n = 548) after TR biopsy. Rate ratios for hospitalization in the TR group compared to TP were 8.0 (95% confidence interval [CI]: 4.0-16.2) for day 1-7, 6.2 (3.2-11.9) for day 1-14, and 4.1 (2.4-6.8) for day 1-30. Filled antibiotic prescriptions were found for 4.5% of men (n = 187) after TP biopsy and 6.9% (n = 1,883) after TR biopsy. For antibiotic prescriptions, the rate ratios were 2.3 (1.8-2.9) for day 1-7 as well as day 1-14, and 1.6 (1.3-1.9) for day 1-30. CONCLUSIONS: A transrectal prostate biopsy was associated with a significantly higher risk of post-biopsy infectious complications compared to transperineal biopsy. These findings support the use of transperineal biopsy.</p>}},
author = {{Bonnedahl, Jesper and Lundström, Karl Johan and Lampa, Erik and Robinson, David and Stranne, Johan and Carlsson, Stefan and Wagenius, Magnus and Linder, Adam and Örtegren, Joakim and Andreasson, Anders and Holmbom, Martin and Stattin, Pär and Styrke, Johan}},
issn = {{2168-1813}},
language = {{eng}},
month = {{03}},
pages = {{44--50}},
publisher = {{Taylor & Francis}},
series = {{Scandinavian Journal of Urology}},
title = {{Risk of infectious complications after transperineal prostate biopsy compared to transrectal biopsy : nationwide population-based cohort study in Sweden}},
url = {{http://dx.doi.org/10.2340/sju.v61.45537}},
doi = {{10.2340/sju.v61.45537}},
volume = {{61}},
year = {{2026}},
}
